Myocardial Injury after Percutaneous Coronary Intervention for In-Stent Restenosis Versus <i>de novo</i> Stenosis-Reference-Cited by-同舟云学术

Myocardial Injury after Percutaneous Coronary Intervention for In-Stent Restenosis Versus de novo Stenosis

Published:2015 Issue:18 Volume:54 Page:2299-2305
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Shimonaga Takashi¹,Kurisu Satoshi¹,Watanabe Noriaki¹,Ikenaga Hiroki¹,Higaki Tadanao¹,Iwasaki Toshitaka¹,Ishibashi Ken¹,Dohi Yoshihiro¹,Fukuda Yukihiro¹,Kihara Yasuki¹

Affiliation:

1. Department of Cardiovascular Medicine, Hiroshima University Graduate School of Biomedical and Health Sciences, Japan

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/internalmedicine/54/18/54_54.5003/_pdf

Reference35 articles.

1. 1. Moses JW, Leon MB, Popma JJ, et al; SIRIUS Investigators. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 349: 1315-1323, 2003.

2. 2. Stone GW, Moses JW, Ellis SG, et al. Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. N Engl J Med 356: 998-1008, 2007.

3. 3. Kaiser C, Galatius S, Erne P, et al; BASKET-PROVE Study Group. Drug-eluting versus bare-metal stents in large coronary arteries. N Engl J Med 363: 2310-2319, 2010.

4. 4. Lansky AJ, Stone GW. Periprocedural myocardial infarction: prevalence, prognosis, and prevention. Circ Cardiovasc Interv 3: 602-610, 2010.

5. 5. Pervaiz MH, Sood P, Sudhir K, et al. Periprocedural myocardial infarction in a randomized trial of everolimus-eluting and paclitaxel-eluting coronary stents: frequency and impact on mortality according to historic versus universal definitions. Circ Cardiovasc Interv 5: 150-156, 2012.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Outcomes of Percutaneous Coronary Intervention for In‐Stent Restenosis Versus De Novo Lesions: A Meta‐Analysis;Journal of the American Heart Association;2023-07-04

2. Eugenol attenuates ischemia-mediated oxidative stress in cardiomyocytes via acetylation of histone at H3K27;Free Radical Biology and Medicine;2023-01

3. Predictive value of inflammatory factors on coronary restenosis after percutaneous coronary intervention in patients with coronary heart disease;Medicine;2021-04-02

4. Effects of Tirofiban and Nicorandil on Effective Reperfusion and the Levels of IL-4 and sICAM-1 After PCI for Chronic Coronary Total Occlusion;Cardiovascular Innovations and Applications;2021

5. Meta-Analysis of Randomized Controlled Trials investigating tirofiban combined with conventional drugs by intracoronary administration for no-reflow prevention;The Anatolian Journal of Cardiology;2020